Will the FDA approve the RAS inhibitor drug daraxonrasib (JAB-21822) for any indication by the end of 2026?

Will the FDA approve the RAS inhibitor drug daraxonrasib (JAB-21822) for any indication by the end of 2026? | Prophecy